The world’s largest medical publisher, Elsevier, has expressed embarrassment at its role in a deceptive marketing ploy by the giant drug company Merck after it was revealed in a Melbourne court.
Elsevier said it had failed to meet its own “high standards for disclosure” when it produced a magazine that pretended to be an independent scientific journal but was actually a marketing front for Merck’s anti-inflammatory drug Vioxx.
Between 2003 and 2005, Elsevier produced several issues of a magazine called The Australasian Journal of Bone and Joint Medicine, which carried articles about Merck’s medicines Fosamax and Vioxx without any disclosure it was funded by Merck.
Source: The Australian
See Also: Full Text of Statement by CEO Of Elsevier’s Health Sciences Division
This entry was posted
on Thursday, May 7th, 2009 and is filed under Information Industry, Scholarly Publishing.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.